Cargando…
Phylogenetic Analysis and Emerging Drug Resistance against Different Nucleoside Analogues in Hepatitis B Virus Positive Patients
Several nucleotide analogues have been approved for use in treating hepatitis B virus (HBV) infection. Long-term exposure to therapy leads to the emergence of mutations within the HBV DNA polymerase gene, resulting in drug resistance, a major factor contributing to therapy failure. Chronic HBV patie...
Autores principales: | Gohar, Maryam, Rehman, Irshad Ur, Ullah, Amin, Khan, Muhammad Ajmal, Yasmin, Humaira, Ahmad, Jamshaid, Butt, Sadia, Ahmad, Ajaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673510/ https://www.ncbi.nlm.nih.gov/pubmed/38004634 http://dx.doi.org/10.3390/microorganisms11112622 |
Ejemplares similares
-
Phylogenetic analysis of the 5ʹ untranslated region of HCV from cirrhotic patients in Khyber Pakhtunkhwa, Pakistan
por: Ullah, Amin, et al.
Publicado: (2021) -
Hepatitis C virus genotype 3a with phylogenetically distinct origin is circulating in Pakistan
por: Rehman, Irshad-ur, et al.
Publicado: (2011) -
Circulating miRNA-192 and miR-29a as Disease Progression Biomarkers in Hepatitis C Patients with a Prevalence of HCV Genotype 3
por: Ullah, Amin, et al.
Publicado: (2023) -
SARS-CoV-2 RNA Dependent RNA polymerase (RdRp) – A drug repurposing study
por: Ahmad, Jamshaid, et al.
Publicado: (2020) -
Mixed Genotype Infections with Hepatitis C Virus, Pakistan
por: Butt, Sadia, et al.
Publicado: (2011)